Rani Therapeutics LLC has issued an offer letter to Nicholas M. Maestas to serve as its new Chief Financial Officer, effective June 29, 2026. The hiring of a new CFO marks a significant leadership transition for the biotechnology company, potentially influencing its financial oversight and strategic direction.